KRRO PE Ratio & Valuation,Is KRRO Overvalued

KRRO Relative Valuation

KRRO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KRRO is overvalued; if below, it's undervalued.

Historical Valuation

Korro Bio Inc (KRRO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.82. The fair price of Korro Bio Inc (KRRO) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：8.28

Fair

-1.05

0.00

EV/EBITDA

Korro Bio Inc. (KRRO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-0.21

EV/EBIT

Korro Bio Inc. (KRRO) has a current EV/EBIT of -0.21. The 5-year average EV/EBIT is -3.05. The thresholds are as follows: Strongly Undervalued below -7.60, Undervalued between -7.60 and -5.32, Fairly Valued between -0.77 and -5.32, Overvalued between -0.77 and 1.51, and Strongly Overvalued above 1.51. The current Forward EV/EBIT of -0.21 falls within the Overvalued range.

40.52

Korro Bio Inc. (KRRO) has a current PS of 40.52. The 5-year average PS is 72.79. The thresholds are as follows: Strongly Undervalued below -242.09, Undervalued between -242.09 and -84.65, Fairly Valued between 230.22 and -84.65, Overvalued between 230.22 and 387.66, and Strongly Overvalued above 387.66. The current Forward PS of 40.52 falls within the Historic Trend Line -Fairly Valued range.

-1.78

P/OCF

Korro Bio Inc. (KRRO) has a current P/OCF of -1.78. The 5-year average P/OCF is -4.41. The thresholds are as follows: Strongly Undervalued below -8.74, Undervalued between -8.74 and -6.58, Fairly Valued between -2.25 and -6.58, Overvalued between -2.25 and -0.08, and Strongly Overvalued above -0.08. The current Forward P/OCF of -1.78 falls within the Overvalued range.

-1.52

P/FCF

Korro Bio Inc. (KRRO) has a current P/FCF of -1.52. The 5-year average P/FCF is -4.11. The thresholds are as follows: Strongly Undervalued below -8.02, Undervalued between -8.02 and -6.07, Fairly Valued between -2.16 and -6.07, Overvalued between -2.16 and -0.20, and Strongly Overvalued above -0.20. The current Forward P/FCF of -1.52 falls within the Overvalued range.

Korro Bio Inc (KRRO) has a current Price-to-Book (P/B) ratio of 0.76. Compared to its 3-year average P/B ratio of 1.83 , the current P/B ratio is approximately -58.74% higher. Relative to its 5-year average P/B ratio of 1.83, the current P/B ratio is about -58.74% higher. Korro Bio Inc (KRRO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -31.74%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -31.74% , the current FCF yield is about -100.00% lower.

0.78

P/B

Median3y

1.83

Median5y

1.83

-93.70

FCF Yield

Median3y

-31.74

Median5y

-31.74

Competitors Valuation Multiple

The average P/S ratio for KRRO's competitors is 39.28, providing a benchmark for relative valuation. Korro Bio Inc Corp (KRRO) exhibits a P/S ratio of , which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of KRRO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of KRRO in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Korro Bio Inc (KRRO) currently overvalued or undervalued?

What is Korro Bio Inc (KRRO) fair value?

KRRO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Korro Bio Inc (KRRO) is between to according to relative valuation methord.

How does KRRO's valuation metrics compare to the industry average?

The average P/S ratio for KRRO's competitors is 39.28, providing a benchmark for relative valuation. Korro Bio Inc Corp (KRRO) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Korro Bio Inc (KRRO) as of Dec 17 2025?

As of Dec 17 2025, Korro Bio Inc (KRRO) has a P/B ratio of 0.76. This indicates that the market values KRRO at 0.76 times its book value.

What is the current FCF Yield for Korro Bio Inc (KRRO) as of Dec 17 2025?

As of Dec 17 2025, Korro Bio Inc (KRRO) has a FCF Yield of 0.00%. This means that for every dollar of Korro Bio Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Korro Bio Inc (KRRO) as of Dec 17 2025?

As of Dec 17 2025, Korro Bio Inc (KRRO) has a Forward P/E ratio of -1.01. This means the market is willing to pay $-1.01 for every dollar of Korro Bio Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Korro Bio Inc (KRRO) as of Dec 17 2025?

As of Dec 17 2025, Korro Bio Inc (KRRO) has a Forward P/S ratio of 0.00. This means the market is valuing KRRO at $0.00 for every dollar of expected revenue over the next 12 months.

KRRO Valuation